Europe — EMA
Noradrenaline Zentiva (Norepinephrine)
GNH USA supplies Noradrenaline Zentiva (Norepinephrine), a vasopressor for acute hypotension, septic shock and cardiogenic shock.
Request sourcing
What is Norepinephrine?
Norepinephrine, the active ingredient in Noradrenaline Zentiva, is a sympathomimetic (vasopressor) presented as an injection solution for intravenous use. It is employed to raise blood pressure in acute hypotension, septic shock and cardiogenic shock in hospitalized patients.
GNH USA supplies Noradrenaline Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Norepinephrine used for?
Noradrenaline Zentiva acts as a potent vasopressor in critical‑care cardiovascular emergencies.
Acute hypotension: rapidly restores systemic blood pressure to maintain organ perfusion. Septic shock: improves vascular tone and supports hemodynamic stability. Cardiogenic shock: enhances cardiac contractility and systemic circulation.
What are the side effects of Norepinephrine?
Adverse reactions may occur with norepinephrine administration.
Common Side Effects: - Tachycardia: increased heart rate. - Headache: pressure sensation. - Peripheral ischemia: reduced blood flow to extremities. - Nausea: gastrointestinal discomfort.
Serious or Rare Side Effects: - Myocardial infarction: heart muscle injury. - Severe hypertension: dangerously high blood pressure. - Tissue necrosis at infusion site: local tissue death due to extravasation.
What precautions apply to Norepinephrine?
Use of norepinephrine requires careful clinical monitoring.
Monitor blood pressure: adjust infusion to target values. Assess cardiac function: watch for arrhythmias. Avoid extravasation: use central venous access when possible. Adjust infusion rate gradually: prevent sudden hemodynamic shifts. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Norepinephrine interact with?
Norepinephrine can interact with several drug classes.
Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Tricyclic antidepressants: additive vasoconstriction. - Beta‑blockers: may blunt desired cardiac effects.
Moderate Interactions (Monitor Closely): - ACE inhibitors: potential for exaggerated hypotension after discontinuation. - Diuretics: may enhance volume depletion and affect response.



